Pharmacists in the emergency department play a crucial role in upfront decision making around medicines for patients presenting with various medical conditions.
Cristina Roman, is the Lead Pharmacist at Alfred Emergency Trauma Centre. In her 12 years working in the Emergency Department, Cristina has established pharmacy services, and filled gaps in patient care with new models of care.
One of those models of care adopted by the US and other countries, is involving pharmacists for critically unwell patients that present to the emergency department.
Through her investigations, Cristina has considered how pharmacy services can impact stroke care, sepsis and trauma outcomes.
Thrombolytic therapy is crucial in ischaemic strokes, as every minute with a blood clot in the brain increases the risk of permanent disability for the patient.
Pharmacists can play a crucial role in identifying patients appropriate for thrombolysis and assisting with the administration of high-risk medications like thrombolysis for stroke patients. This can mean faster thrombolysis to eligible patients, shaping the scope of practice for the emergency medicine pharmacist.
In addition, her studies have also shown the involvement of pharmacists in sepsis calls improves time to antibiotic administration, particularly for patients in ICU care. The evidence has shown better outcomes for the most unwell patients.
Nurses and medical staff at Alfred Hospital are now actively pulling pharmacists into scenarios, highlighting the value and benefit of their involvement in patient care.
This model of care for emergency departments involving pharmacists has gained international interest and is continuing to expand.
Australian Health Journal spoke with Cristina Roman and Lisa Bremner, Advanced Training Resident Pharmacist at Alfred Hospital Emergency Trauma Centre.
-
Growing impact of blood cancer on women
According to the Leukaemia Foundation, blood cancer is one of the most urgent and under-recognised women’s health issues in Australia, with three times more Australian women diagnosed with blood cancer than ovarian and cervical cancer combined (Source: AIHW, Cancer Data in Australia, 2024).
Blood cancer has also emerged as the second most common cancer diagnosed in Australian women overall – behind only breast cancer – and the leading cancer amongst girls and women under the age of 30 (Source: AIHW, Cancer Data in Australia, 2024).
-
Improved treatment in advanced-stage Hodgkin lymphoma
A global clinical trial successfully reduced toxicity and side effects in advanced stage Hodgkin lymphoma patients by using a modified treatment regimen.
Australian Health Journal spoke with Professor Mark Hertzberg in his role in the ALLG HD10 Clinical Trial and as a former Chair of the Scientific Advisory Committee of the Australasian Leukaemia & Lymphoma Group (ALLG), an organisation involved in improving the treatments and lives of blood cancer patients.
-
Still seeking outcomes after 6th Stoma Appliance Scheme Schedule Review
50,000 Australians have undergone the trauma and challenge of having a stoma inserted. Whilst the Australian Government invests in the appliances and products they need through the Stoma Appliance Scheme (SAS), this list is dated and doesn’t include as many of the products available in other countries. A new report commissioned by the Stoma Industry Association (SIA) shows Australia lagging countries such as the United Kingdom, Canada and Spain in supporting ostomates (people with a stoma).
